14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CSTL
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for Castle Biosciences, Inc.
(Updated on May 08, 2024)

Buy or Hold candidate since Apr 29, 2024 Gain 9.34% PDF

The Castle Biosciences, Inc. stock price fell by -1.07% on the last day (Wednesday, 8th May 2024) from $23.80 to $23.54. During the last trading day the stock fluctuated 3.58% from a day low at $23.16 to a day high of $23.99. The price has risen in 6 of the last 10 days and is up by 18.53% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -147 thousand shares and in total, 172 thousand shares were bought and sold for approximately $4.04 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $24.33 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -8.88% during the next 3 months and, with a 90% probability hold a price between $14.75 and $22.17 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CSTL Signals & Forecast

The Castle Biosciences, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $23.15 and $21.08. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, May 06, 2024, and so far it has fallen -3.56%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Castle Biosciences, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $22.31 and $19.94. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Castle Biosciences, Inc. finds support just below today's level at $22.31. If this is broken, then the next support from accumulated volume will be at $19.94 and $18.06.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.83 between high and low, or 3.58%. For the last week, the stock has had daily average volatility of 6.31%.

The Castle Biosciences, Inc. stock is overbought on RSI14 and the RSI has been falling for the last couple of days. This together with the fact that the stock is in the upper part of the trend poses a possible good selling opportunity for the short-term trader. However, one should note that some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $22.42 (-4.74%) (This stock has high daily movements and this gives high risk. The RSI14 is 77 and this increases the risk substantially. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (CSTL) For The Upcoming Trading Day Of Thursday 9th

For the upcoming trading day on Thursday, 9th we expect Castle Biosciences, Inc. to open at $23.56, and during the day (based on 14 day Average True Range), to move between $22.44 and $24.64, which gives a possible trading interval of +/-$1.10 (+/-4.68%) up or down from last closing price. If Castle Biosciences, Inc. takes out the full calculated possible swing range there will be an estimated 9.36% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $24.33 (3.36%) than the support at $22.31 (5.23%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Castle Biosciences, Inc. stock A Buy?

Castle Biosciences, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.860 Hold/Accumulate Unchanged

Predicted Opening Price for Castle Biosciences, Inc. of Thursday, May 9, 2024

Fair opening price May 9, 2024 Current price
$23.56 ( 0.0991%) $23.54

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CSTL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 24.39 3.63 %
R2 24.08 2.28 %
R1 23.88 1.45 %
Current price: 23.54
Support S1 23.25 -1.25 %
S2 23.05 -2.08 %
S3 22.73 -3.43 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 25.09 6.58 %
R2 24.41 3.70 %
R1 24.33 3.36 %
Current price 23.54
Support S1 22.31 -5.23%
S2 19.94 -15.29%
S3 18.06 -23.28%

FAQ

What is the symbol for Castle Biosciences, Inc. Stock and on which exchange is it traded?
The symbol for Castle Biosciences, Inc. is CSTL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Castle Biosciences, Inc. Stock?
Castle Biosciences, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Castle Biosciences, Inc. Stock?
Castle Biosciences, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Castle Biosciences, Inc. Stock.

What's the current price of Castle Biosciences, Inc. Stock?
As of the end of day on the May 08, 2024, the price of an Castle Biosciences, Inc. (CSTL) share was $23.54.

What is the 52-week high and low for Castle Biosciences, Inc. Stock?
The 52-week high for Castle Biosciences, Inc. Stock is $46.28 and the 52-week low is $36.31.

What is the market capitalization of Castle Biosciences, Inc. Stock?
As of the May 08, 2024, the market capitalization of Castle Biosciences, Inc. is 649.873M.

When is the next earnings date for Castle Biosciences, Inc.?
The upcoming earnings date for Castle Biosciences, Inc. is Aug 07, 2024.
Click to get the best stock tips daily for free!

About Castle Biosciences, Inc.

Castle Biosciences. Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients w... CSTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT